Delayed embryonic development or a long sperm survival in two mares-A registration conundrum.

Equine Vet J. January 2024;56(1):131 - 136.

Patrick M McCue¹, Philip M Matthews², Melissa J Prell³, Rebecca R Bellone⁴, Heather Allen⁵

¹ Equine Reproduction Laboratory, Colorado State University, Fort Collins, Colorado, USA.; ² Peterson Smith Advanced Fertility Center, Peterson & Smith Equine Hospital, Ocala, Florida, USA.; ³ Peterson Smith Advanced Fertility Center, Peterson & Smith Equine Hospital, Ocala, Florida, USA.; ⁴ Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California, Davis, California, USA.; ⁵ Bureau Veritas Laboratories, Guelph, Ontario, Canada.

Abstract

BACKGROUND:Genetic testing is required for the registration of foals of most equine breeds.

OBJECTIVES:To describe two clinical cases of marked delayed embryonic development or delayed fertilisation in pregnancies generated by embryo transfer.

STUDY DESIGN:Case report.

METHODS:Donor mares were inseminated with semen from one stallion during one oestrous cycle and semen from a different stallion on the subsequent oestrous cycle. Embryo(s) were collected 8 days after ovulation during the second oestrous cycle and transferred into synchronised recipient mares. Genetic testing was performed to determine parentage of the two foals.

RESULTS:For both foals, DNA parentage testing excluded the second stallion as the genetic sire and confirmed that the first stallion, whose semen was inseminated on the previous oestrous cycle, was the actual genetic sire.

MAIN LIMITATIONS:Rare event in horses; two clinical cases are described.

CONCLUSIONS:It is hypothesised that either marked delayed embryonic development or extended sperm survival occurred in the donor mares. Without genetic testing, parentage assignment based solely on breeding records would have been incorrect.

Keywords

DNA; delayed; embryonic development; horse; parentage;

Article Tools:

Medline

Email to me

Archives Highlights:

The Ideal Canine Companion: Re-Exploring Australian Perspectives on Ideal Characteristics for Companion Dogs.
The ideal dog was characterised as medium-sized, with a short- low- or non-shedding coat, and acquired as a puppy from a shelter/rescue. Desired traits included being affectionate, healthy, non-aggressive, safe with children, housetrained, non-destructive when alone, and not prone to escaping.

Limb amputation for feline appendicular bone tumors results in excellent recovery outcomes and high owner satisfaction with a low incidence of complications.
Time to return to walking without support was < 3 days in 69.7% of cats and 3 to 7 days in 16.7%. Activity level changes were reported as no change in 75.8% of cats. There were no behavioral changes in 92.3% of cats. Quality of life following amputation was recorded as excellent in 82.4% of cats. Owner satisfaction was reported as very satisfied, moderately satisfied, or satisfied in 98.5% of cats.

Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma.
The median time to distant progression for all dogs was 265 days, with no significant difference between treatment groups. The median overall survival for all dogs was 270 days, and it was significantly different between amputated dogs (150 days) and those also receiving adjuvant chemotherapy (353 days). In our cohort, osteosarcoma in small breeds behaved as aggressive as in large breeds.

Owner survey suggests cats may be undertreated for pain compared to dogs after an elective ovariohysterectomy or orchiectomy.
Analgesics were prescribed for 19 of 162 (12%) pets: 14 of 88 (16%) dogs and 5 of 74 (6.7%) cats. There was no difference in the prescription of analgesics between dogs and cats after ovariohysterectomy or orchiectomy. 15 of 19 owners reported their compliance in administering analgesics at 78.9%. Owners' subjective assessments showed that 24 of 86 (28%) dogs and 12 of 68 (17%) cats appeared painful at home.

Factors Associated with Medication Noncompliance in Dogs in New Zealand.
Medication noncompliance was recorded for 47% (71/151) of owners. Increasing dog age was associated with better owner compliance. Forty-seven percent (71/151) of owners reported that "nobody" showed them how to administer the medication. One-third of dog owners (47/151) reported challenges in medicating their pets. The most common reason cited by clients reporting challenges was a resistant pet.